INS and diabetes mellitus: However, a nearly 50% decrease in DDDc of insulin does not directly indicate that patients with diabetes have reduced the same expenditure, since insulin expenditure is only a part of the expenditure of patients with diabetes, and there may even be a compensatory cost shift phenomenon that other diabetes-related treatment or examination expenses increased after the decrease in insulin price.